Calypso Medical And IMPAC Medical Systems To Develop Motion Management Solutions

Seattle and Sunnyvale, CA - Calypso Medical and IMPAC Medical Systems, an Elekta company, have identified product collaboration projects which will further enable integration of oncology management systems with the Calypso 4D Localization System. Designed to provide an objective and continuous method to setup patients for radiation treatment, the Calypso System monitors the patient during treatment without adding ionizing radiation.

"Calypso Medical plans to work with IMPAC to provide our customers with innovative approaches to real-time organ motion management from patient setup through treatment," says Eric R. Meier, President and CEO of Calypso Medical. "We anticipate workflow gains that will further solidify our platform as ideal and unique by providing continuous and real-time target localization solutions."

Precise setup, consistent delivery, and accurate treatment documentation are critical to radiation oncology. With this product collaboration, customers will be able to more efficiently manage organ motion with the addition of new features such as the capability of remote table repositioning. Accurate and precise delivery of radiation treatment will be ensured by correcting for motion detected by the Calypso System prior to and during the actual treatment.

"IMPAC is looking forward to working closely with Calypso Medical to optimize our customers' clinical workflow in managing the challenges associated with organ motion," says Jay Hoey, Executive Vice President Product Creation at Elekta and CEO of IMPAC Medical Systems. "The real-time motion data generated by the Calypso System introduces new and exciting options which will advance adaptive radiation therapy approaches, as well as provide data management solutions for our mutual customers."

About Calypso Medical
Calypso Medical Technologies, Inc. ("Calypso") is a Seattle, WA based privately held medical device company. The Company's proprietary tumor localization system utilizes miniaturized implanted devices (Beacon electromagnetic transponders) to continuously, accurately, and objectively pinpoint the location of tumors for improved accuracy in radiation therapy. Calypso addresses two major issues in modern radiation oncology: errors in treatment set-up and tumor motion during treatment. In addition, the Calypso 4D Localization System's non-ionizing electromagnetic guidance has been found to improve work flow efficiency and treatment room utilization. The technology is designed for body-wide cancers commonly treated with radiation therapy, including prostate, breast, lung, head, neck and other radiation therapy target organs. The products are FDA 510(k) cleared for use in the prostate only.

Calypso, Beacon, GPS for the Body, Motion Matters, Nothing Tracks Like the Beacon, Calypso Within, Beacon Within, 4D Console, 4D Electromagnetic Array, 4D Tracking Station, On Target, On With Living and/or other Calypso Medical Technologies, Inc.'s products referenced herein are either registered trademarks or trademarks in use of Calypso Medical Technologies, Inc. The names of actual companies and products mentioned herein may be the trademarks of their respective owners. Any rights not expressly granted herein are reserved.

About Elekta and IMPAC
Elekta Inc., IMPAC Medical Systems, Medical Intelligence and 3D Line Medical Systems are all part of the Elekta Group, an international medical technology corporation, providing meaningful solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. Elekta is listed on the Nordic Exchange under the ticker EKTAb and the company head office is located in Stockholm, Sweden. For additional information, please visit www.elekta.com and www.impac.com.

SOURCE: Calypso Medical and IMPAC Medical Systems